Phase II trial of the histone deacetylase inhibitor belinostat in women with platinum resistant epithelial ovarian cancer and micropapillary (LMP) ovarian tumours.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples